Vancomycin® Hydrochloride for Injection USP 1gm

Description

Vancomycin injection is a powerful antibiotic used to treat serious bacterial infections caused by gram-positive organisms, particularly when other antibiotics are ineffective or inappropriate. It belongs to a class of antibiotics called glycopeptides.

Common Uses:

Severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

Infections caused by Enterococcus species, especially resistant strains (except Vancomycin-resistant Enterococcus, VRE).

Severe skin and soft tissue infections.

Bone and joint infections (e.g., osteomyelitis).

Endocarditis.

Pneumonia.

Sepsis.

Clostridium difficile-associated diarrhea (off-label) as an intravenous adjunct, though oral vancomycin is preferred.

Administration:

Route: Intravenous (IV). It is not absorbed orally for systemic infections, so injections are used for treating systemic conditions.

Dosage: Varies based on the patient’s weight, renal function, and severity of the infection. Serum levels (trough concentrations) are monitored to ensure therapeutic levels and avoid toxicity.

Duration: Depends on the type and severity of the infection.

Key Considerations:

1. Infusion-related reactions:

Red man syndrome: A reaction characterized by flushing, rash, and itching, usually due to rapid infusion. It is prevented by slowing the infusion rate.

Infuse over 1–2 hours to minimize risks.

2. Toxicity:

Nephrotoxicity: Monitor kidney function (e.g., serum creatinine).

Ototoxicity: Rare but possible; monitor for hearing loss.

3. Renal dosing:

Adjust dose in patients with renal impairment due to the drug’s elimination through the kidneys.

4. Monitoring:

Trough levels are typically measured before the 4th dose. Therapeutic range: 10–20 µg/mL (or higher for serious infections).

Side Effects:

Pain and irritation at the injection site.

Nausea or upset stomach.

Allergic reactions (rare but possible).

Changes in blood cell counts (e.g., neutropenia, thrombocytopenia in rare cases).

Drug Interactions:

Other nephrotoxic or ototoxic drugs (e.g., aminoglycosides, furosemide) increase the risk of toxicity.